No results for ‘’
Glaxosmithkline Pharmaceuticals Ltd
₹2875
(0.42%)
Sun, 27 Sept 2026, 08:57 pm
Health Technology
Pharmaceuticals: Major
24.5KGlaxosmithkline Pharmaceuticals Share Price Live Chart
1 Day
(0.42%)
No Result Found
Summary
Market Cap (in Cr)
37416.71
Net Profit (in Cr)
927.58
P/B
24.98
Sector P/E
33.76
P/E
52.54
EV/EBITDA
35.66
Debt/Equity (Industry)
0.08
Interest Cover (Industry)
42.77
ROCE (Industry)
23.88
RONW (Industry)
19.04
ROE
49.75
ROCE
59.29
Debt/Equity
0.01
EPS (TTM)
60.26
Dividend Yield
2.58
Book Value
133.85
Interest Cover
962.74
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends after 3 years are expected to be covered by earnings (1.5x coverage).
- GlaxoSmithKline Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- GlaxoSmithKline Pharmaceuticals's earnings are expected to grow significantly at over 20% yearly.
- GlaxoSmithKline Pharmaceuticals's earnings growth is expected to exceed the India market average.
- Dividends paid are not well covered by earnings (0.3x coverage).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- GlaxoSmithKline Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for GlaxoSmithKline Pharmaceuticals is expected to increase but not above the 50% threshold in 2 years time.
- GlaxoSmithKline Pharmaceuticals's revenue is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 75 | 75 | 75 | 75 | 75 |
| FII | 4.62 | 4.64 | 4.79 | 4.88 | 4.52 |
| DII | 7.68 | 7.70 | 7.75 | 7.70 | 7.79 |
| Public | 12.70 | 12.66 | 12.45 | 12.41 | 12.69 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 4106.67 | 3500.97 | 3275.53 | 2895.27 | 2669.83 | 2289.57 | 1683.87 |
| Fibonacci | 3500.97 | 3269.59 | 3126.64 | 2895.27 | 2663.89 | 2520.94 | 2289.57 |
| Camarilla | 3216.67 | 3161.14 | 3105.62 | 2895.27 | 2994.58 | 2939.05 | 2883.53 |
Pivots Level: Classic
R3
+1211.40
4106.67
R2
+605.70
3500.97
R1
+380.27
3275.53
S1
-225.43
2669.83
S2
-605.70
2289.57
S3
-1211.40
1683.87
Moving Average
Period
Value
10-EMA
2852.56
20-EMA
2860.75
30-EMA
2839.70
50-EMA
2773.47
100-EMA
2656.91
200-EMA
2596.08
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 13 May 2026 | board-meetings | Accounts, Quarterly Results, Dividend | |
| 13 May 2026 | agm | ||
| 13 May 2026 | dividend | ₹57.00 Dividend /Share | 29 May 2026 |
| 09 Feb 2026 | board-meetings | Quarterly Results | |
| 06 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 13 May 2025 | agm | ||
| 13 May 2025 | dividend | ₹42.00 Dividend /Share | 30 May 2025 |
| 30 Apr 2025 | dividend | Final Dividend - Rs. - 42 | 30 May 2025 |
| 29 Oct 2024 | dividend | ₹12.00 Dividend /Share | 07 Nov 2024 |
| 07 Oct 2024 | dividend | Interim Dividend - Rs. - 12 | 07 Nov 2024 |
Peer Comparison
Glaxosmithkline Pharmaceuticals Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Glaxosmithkline Pharmaceuticals Ltd About
GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.
Industry
Pharmaceuticals - Multinational
Founded
1924
Headquarters
CEO
Renu S Karnad
Employees
Contact
Website
http://www.gsk-india.com
askus@gsk.com; ajay.a.nadkarni@gsk.com
Phone
91-022-24959595
Location
GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030
Glaxosmithkline Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2019 |
|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11373 | 1424.4 | 03 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11373 | 1424.4 | 03 Oct 2022 |
Frequently Asked Questions
1.What is the stock price of Glaxosmithkline Pharmaceuticals Ltd?
As of 28/09/2026 at 2:27 AM, Glaxosmithkline Pharmaceuticals Ltd shares are trading at ₹2875.
2.What is the market cap. of Glaxosmithkline Pharmaceuticals Ltd?
As of 28/09/2026, the market capitalization of Glaxosmithkline Pharmaceuticals Ltd is ₹48,517.04 crore.
3.When was Glaxosmithkline Pharmaceuticals Ltd founded?
Glaxosmithkline Pharmaceuticals Ltd was founded in 1924.
4.What are the P/E and P/B ratios of Glaxosmithkline Pharmaceuticals Ltd?
As of 28/09/2026, Glaxosmithkline Pharmaceuticals Ltd has a P/E ratio of 45.60 and a P/B ratio of 24.98.
5.How can I buy shares of Glaxosmithkline Pharmaceuticals Ltd?
You can buy shares of Glaxosmithkline Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd?
As of March,2026, promoters hold 75.00% in Glaxosmithkline Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 4.62%, 7.68% and 12.70%, respectively. The government holds 0.00%.
7.Does Glaxosmithkline Pharmaceuticals Ltd pay dividends?
Yes, Glaxosmithkline Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹57.00 Dividend /Share per share.
8.What is the dividend yield of Glaxosmithkline Pharmaceuticals Ltd?
As of 28 September, 2026, the dividend yield of Glaxosmithkline Pharmaceuticals Ltd stands at 2.00%.
9.What are the latest financial results of Glaxosmithkline Pharmaceuticals Ltd?
For January,2024, Glaxosmithkline Pharmaceuticals Ltd reported revenue of ₹3,749.00 crore and a net profit of ₹928.00 crore.
10.What is the Stock symbol of Glaxosmithkline Pharmaceuticals Ltd?
GLAXO is the stock symbol of Glaxosmithkline Pharmaceuticals Ltd.
11.Who is the CEO of Glaxosmithkline Pharmaceuticals Ltd?
The CEO of Glaxosmithkline Pharmaceuticals Ltd is Renu S Karnad.